Product Information
VENLAFAXINE BES ER 112.5 MG TB is a generic product labeled by Almatica Pharma LLC, priced at $6.2298 per EA under NDC 52427063230. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Jun 29, 2022.
The High Outlier badge above means this manufacturer's average price in the venlafaxine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
112.5 mg/1
Manufacturer
Almatica Pharma LLCNDC
52427063230
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VENLAFAXINE BESYLATE MONOHYDRATEApproval Type
New Drug (NDA)
FDA Application
NDA215429FDA Approved
6/29/2022
On Market Since
6/30/2022
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE BES ER 112.5 MG TB has been published 129 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.2298 per EA |
|---|---|
| All-time high | $6.2298 (Sep 30, 2026) |
| All-time low | $6.1722 (Apr 22, 2026) |
| 52-week high | $6.2298 |
| 52-week low | $6.1722 |
| Median price | $6.1878 |
| Average price | $6.1917 |
| Largest weekly change | +0.8% (Sep 23, 2026) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the venlafaxine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Almatica Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
venlafaxine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin and Norepinephrine Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VENLAFAXINE BES ER 112.5 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE BES ER 112.5 MG TB, manufactured by Almatica Pharma LLC, is $6.2298 per EA (NDC 52427063230), effective Sep 30, 2026.
How has the price of VENLAFAXINE BES ER 112.5 MG TB changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE BES ER 112.5 MG TB has held within roughly two percent of its current level. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE BES ER 112.5 MG TB?
Since Apr 17, 2024, the NADAC for VENLAFAXINE BES ER 112.5 MG TB has ranged from a low of $6.1722 (Apr 22, 2026) to a high of $6.2298 (Sep 30, 2026), with a median of $6.1878 per EA.
Are there cheaper alternatives to VENLAFAXINE BES ER 112.5 MG TB?
No other NADAC-published product currently shares the active ingredient and strength of VENLAFAXINE BES ER 112.5 MG TB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VENLAFAXINE BES ER 112.5 MG TB?
VENLAFAXINE BES ER 112.5 MG TB (NDC 52427063230) is labeled by Almatica Pharma LLC, and CMS classifies it as a generic product.